Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
Journal article
Adhikari B. et al, (2021), Malaria journal, 20
Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria
Journal article
Awab GR. et al, (2021), eLife, 10
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.
Journal article
Rakmark K. et al, (2020), Malaria journal, 19
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Journal article
Newton PN. et al, (2020), The Lancet Global Health, 8, e754 - e755
Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data
Journal article
Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), BMC Medicine, 17
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Journal article
Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
Journal article
Commons RJ. et al, (2018), The Lancet Infectious Diseases, 18, 1025 - 1034
Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial
Journal article
Awab GR. et al, (2017), The American Journal of Tropical Medicine and Hygiene, 97, 1782 - 1787
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Journal article
Awab GR. et al, (2016), Malaria Journal, 15
A Worldwide Map ofPlasmodium falciparumK13-Propeller Polymorphisms
Journal article
Ménard D. et al, (2016), New England Journal of Medicine, 374, 2453 - 2464
Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Journal article
(2015), BMC Infectious Diseases, 15
A Population Survey of the Glucose-6-Phosphate Dehydrogenase (G6PD) 563C>T (Mediterranean) Mutation in Afghanistan
Journal article
Jamornthanyawat N. et al, (2014), PLoS ONE, 9, e88605 - e88605
The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data
Journal article
(2013), PLoS Medicine, 10, e1001564 - e1001564
Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
Journal article
Awab GR. et al, (2013), Malaria Journal, 12
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
Journal article
Awab GR. et al, (2010), Malaria Journal, 9